Разработка термореверсивного вагинального геля с бактериофагами

The urogenital infections of the female genital tract among patients of gynecological departments occupy a leading place in level of disease and recurrence rate. The antibiotic therapy has a number of side effects, such as the limited use among pregnant and lactating women, the development of bacterial resistance, the suppression of normal flora. A solution to these problems in some cases, it may be therapy with bacteriophages. The optimal dosage form for the local treatment of urogenital infections are vaginal gels. The vaginal gels are able to provide local prolonged release of the drug.